Klinische Wochenschrift

, Volume 64, Issue 9, pp 401–404 | Cite as

Hypothesis: Selective ineffective humoral immune responsiveness as a possible cause of certain chronic inflammatory disorders

Theoretical considerations and rationale for treatment
  • A. Hässig
  • H. Cottier
Editorial

Abbreviations

Fcγ

Constant portion of the IgG molecule

HLA

Human leukocyte antigens

ITP

Idiopathic thrombocytopenic purpura

IVIG

Intravenous administration of high doses of pooled polyclonal human immunoglobulin of the 7S IgG class

MHC

Major histocompatibility gene complex

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Al Kadiry W, Gold RG, Behan PO, Mowbray JF (1983) Analysis of antigens in the circulating immune complexes of patients with Coxsackie infections. In: Immunology of nervous system infections (Progress in brain research, vol 59). Elsevier, Amsterdam, pp 61–67Google Scholar
  2. 2.
    Benacerraf B, Germain RN (1978) The immune response genes of the major histocompatibility complex. Immunol Rev 38:70–119Google Scholar
  3. 3.
    Burton DR (1985) Immunoglobulin G: Functional sites. Mol Immunol 22:161–206Google Scholar
  4. 4.
    Cohen D, Le Gall I, Marcadet A, Font M-P, Lalouel J-M, Dausset J (1984) Clusters of HLA class IIβ restriction fragments describe allelic series. Proc Natl Acad Sci USA 81:7870–7874Google Scholar
  5. 5.
    Cooper NR, Nemerow GR (1983) Complement, viruses, and virus-infected cells. Springer Semin Immunopathol 6:327–347Google Scholar
  6. 6.
    Cottier H, Hässig A (1985) Beneficial effects of intravenous gamma globulin in various chronic inflammatory disorders. Vox Sang (in press)Google Scholar
  7. 7.
    Dwyer JM (1984) Thirty years of supplying the missing link. History of gammaglobulin therapy for immunodeficient states. Am J Med (Suppl 3A) 76:46–52Google Scholar
  8. 8.
    Feurle GE (1985) Association of Whipple's disease with HLA-B27. Lancet I:1336Google Scholar
  9. 9.
    Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T, Kawarano M, Baba K, Baba K, Mori C (1984) High dose intravenous gammaglobulin for Kawasaki disease. Lancet II:1055–1061Google Scholar
  10. 10.
    Gadd SJ, Brogan MP, Ashman LK (1985) Specificity of the passive antibody-induced suppression of the humoral immune response of mice to surface antigens on human cells. Immunology 54:223–231Google Scholar
  11. 11.
    Gros H (1952) Die Behandlung des Herpes zoster mit Humanglobulin. Dtsch Med Wochenschr 77:1074–1076Google Scholar
  12. 12.
    Habich H (1985) Immunoglobulin therapy in ophthalmic diseases. Preliminary results in viral infections (varicella zoster, herpex simplex), intermediate uveitis and allergic forms of keratoconjunctivitis. Thesis, University of BernGoogle Scholar
  13. 13.
    Hanson L, Bjorkander JG, Robbins J, Schneerson R, Sonderstrom R, Sonderstrom T (1985) IgG subclass deficiency. Vox Sang (in press)Google Scholar
  14. 14.
    Hobbs MV, Morgan EL, Weigle WO (1985) Synthetic Fc peptide-mediated regulation of the immune response. II. Analysis of secreted immunoglobulin classes, accessory cell contribution, and lymphocyte proliferation in p23-stimulated spleen cell cultures. J Immunol 134:2847–2852Google Scholar
  15. 15.
    Hood L, Kronenberg M, Hunkapiller T (1985) T cell antigen receptors and the immunoglobulin supergene family. Cell 40:225–229Google Scholar
  16. 16.
    Imbach P, Gaedicke G, Joller P (1984) Interim evaluation of two cooperative studies assessing the effects of intravenous immunoglobulin (i.v. IgG) on childhood idiopathic thrombocytopenic purpura (ITP): I. Randomized study comparing i.v. IgG with oral corticosteroids in previously untreated acute ITP. II. Prospective study of i.v. IgG in acute and chronic ITP unresponsive to previous treatment. Blut 48:357–361Google Scholar
  17. 17.
    Kaufman JF, Auffray Ch, Korman AJ, Shackelford DA, Strominger J (1948) The class II molecules of the human and murine major histocompatibility complex. Cell 36:1–13Google Scholar
  18. 18.
    Klein J, Figueroa F, Nagy ZA (1983) Genetics of the major histocompatibility complex: the final act. Ann Rev Immunol 1:119–142Google Scholar
  19. 19.
    Koch UD (1985) Immunoglobulin therapy for herpes zoster. Thesis, University of BernGoogle Scholar
  20. 20.
    Nagase F, Ponzio NM, Waltenbaugh C, Katz I, Thorbecke GJ (1985) Nonspecific immune modulating effects of ascites fluid and hyperimmune sera in vivo. Cell Immunol 90:92–102Google Scholar
  21. 21.
    Nicholson KG (1984) Antiviral therapy. Varicella-zoster virus infections, herpes labialis and mucocutaneous herpes, and cytomegalovirus infections. Lancet II:677–681Google Scholar
  22. 22.
    Nolte MT, Pirofsky B, Gerritz GA, Golding B (1979) Intravenous immune globulin therapy for antibody deficiency. Clin Exp Immunol 36:237–243Google Scholar
  23. 23.
    Pollack MS, Rich RR (1985) The HLA complex and the pathogenesis of infectious diseases. J Infect Dis 151:1–8Google Scholar
  24. 24.
    Rosen FS, Cooper MD, Wedgwood RJP (1984) The primary immunodeficiencies. N Engl J Med 311:235–242Google Scholar
  25. 25.
    Rosen FS, Cooper MD, Wedgwood RJP (1984) The primary immunodeficiencies. N Engl J Med 311:300–310Google Scholar
  26. 26.
    Rosenbaum JT, McDevitt HO, Guss RB, Egbert PR (1980) Endotoxin-induced uveitis in rats as a model for human disease. Nature 286:611–613Google Scholar
  27. 27.
    Schaffner T, Keller HU, Hess MW, Cottier H (1982) Macrophage functions in antimicrobial defense. Klin Wochenschr 60:720–726Google Scholar
  28. 28.
    Sultan Y, Kazatchkine MD, Maisonneuve P, Nydegger UE (1984) Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet II:765–768Google Scholar
  29. 29.
    Suzuki Y, Oite T, Shimizu F, Yamamoto K, Suzuki S, Arakawa M (1984) Solubilization of immune complex deposits by native 7S IgG molecules in lupus glomerulonephritis — a possible antigen excess effect on rheumatoid factor-IgG complexes. Clin Exp Immunol 58:663–671Google Scholar
  30. 30.
    Templeton JG, Cocker JE, Crawford RJ, Forwell MA, Sandilands GP (1985) Fcγ-receptor blocking antibodies in hyperimmune and normal pooled gammaglobulin. Lancet I:1337Google Scholar
  31. 31.
    Thalhamer J, Freund J (1985) Passive immunization: a method of enhancing the immune response against antigen mixtures. J Immunol Methods 80:7–13Google Scholar
  32. 32.
    van Eden W, Gonzalez NM, de Vries RRP, Convit J, van Rood JJ (1985) HLA-linked control of predisposition to lepromatous leprosy. J Infect Dis 151:9–14Google Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • A. Hässig
    • 1
  • H. Cottier
    • 2
  1. 1.Zentrallaboratorium des Blutspendedienstes des Schweizerischen Roten KreuzesBernSchweiz
  2. 2.Pathologisches InstitutUniversität BernBernSchweiz

Personalised recommendations